|
 |
Nomes comerciais nos diversos países |
|
|
OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.
|
|
Abbocurium |
Polonia |
|
Acurmil |
Itália |
|
Ancour |
Irã |
|
Anecur |
Irã |
|
Atacur |
Arábia Saudita |
|
Atacurin |
Irã |
|
Atrabesylate |
Egipto |
|
Atracur |
Equator |
|
Atracurio |
Argentina, Brasil, Espanha |
|
Atracurio besilato |
Chilli, Itália, Peru, Venezuela |
|
Atracurium |
Alemanha, Arábia Saudita, Argentina, Austria, Egipto, Emirados Árabes Unidos, Gran-bretanha, Irã, Itália, Malásia, Suècia |
|
Atracurium besilat |
Austria |
|
Atracurium besilate |
Arábia Saudita, Australia, Canadá, Egipto, Emirados Árabes Unidos, Estados Unidos de América, Irã, nova Zelândia |
|
Atralex |
Malásia |
|
Atrasyl |
Turquia |
|
Besilato Atracurio |
Chilli, Espanha, Portugal |
|
Besitrac |
Brasil |
|
Faulcurium |
Egipto, Portugal |
|
Gelolagar |
Argentina |
|
Laurak |
Espanha |
|
Neucurium |
Turquia |
|
Notrixum |
Turquia |
|
Relactrac |
Colômbia |
|
Relatrac |
México |
|
Tracrium |
Alemanha, Arábia Saudita, Argentina, Australia, Austria, Bélgica, Chilli, Colômbia, Egipto, Emirados Árabes Unidos, Equator, Espanha, Estados Unidos de América, França, Gran-bretanha, Grècia, Hungria, Irã, Itália, Luxemburgo, Malásia, Marrocos, México, nova Zelândia, Países Baixos, Polonia, Portugal, Romènia, Suècia, Suicia, Tunísia |
|
Tracumek |
Peru |
|
Tracurix |
Argentina |
|
Tracuron |
Argentina |
|
|
 |
 |
Bibliografía : Atracurium besylate |
|
|
tipo |
publicação |
| 285 |
jornal |
Elmore RL, Contois ME, Kelly J, Noe A, Poirier A.
Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
Clin Ther 1996 ; 18: 246-255. |
| 300 |
jornal |
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292. |
| 319 |
jornal |
Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999. |
| 402 |
jornal |
Savitsky ME.
Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 820-821. |
| 657 |
jornal |
Pramar YV, Loucas VA, Word D.
Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes.
J Clin Pharm Ther 1996 ; 21: 173-175. |
| 660 |
jornal |
Michaels MR, Stauffer GL, Haas DP.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Ann Pharmacotherapy 1996 ; 30: 228-232. |
| 813 |
jornal |
Akkermann SR, Zhang H, Mullins RE, Yaughn K.
Stability of milrinone lactate in the presence of 29 critical care drugs and 4 IV solutions.
Am J Health-Syst Pharm 1999 ; 56: 63-68. |
| 865 |
jornal |
Bhatt-Mehta V, Hirata S.
Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
Int J Pharm Compound 1998 ; 2: 79-81. |
| 939 |
jornal |
Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170. |
| 1093 |
jornal |
Fisher DM, Canfell, Miller RD.
Stability of atracurium administered by infusion.
Anesthesiology 1984 ; 61: 347-348. |
| 1611 |
jornal |
Chalmers JR, Bobek MB, Militello MA.
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Am J Health-Syst Pharm 2001 ; 58: 504-506. |
| 1647 |
jornal |
Ackland G.
Physical incompatibility between atracurium and intravenous diclofenac.
Anaesthesia 2001 ; 56: 294. |
| 1721 |
jornal |
Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72. |
| 1803 |
jornal |
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85. |
| 3373 |
jornal |
Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58. |
| 3502 |
Laboratório |
Propofol (Diprivan®) - Summary of Products Characteristics
Astra Zeneca 2012 |
| 3629 |
Laboratório |
Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
Actavis UK 2014 |
| 3659 |
Laboratório |
Propofol (Diprivan®) - Résumé des caractéristiques du produit
AstraZeneca 2016 |
| 3676 |
Laboratório |
Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
Hospira 2014 |
| 4428 |
jornal |
Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J.
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132. |
|
|
